Form 8-K Genufood Energy Enzymes For: Aug 16
- Wall St rallies as data, RBA move lifts hope of Fed easing
- Twitter (TWTR) Jumps On Reports Musk Will Go-Ahead with Deal at Original Price
- $22 Billion in 'Unrelenting' New Short Positions Were Added Last Week - Citi
- Why is Credit Suisse in Trouble? All You Need to Know
- No Full Capitulation on Wall Street Yet - Bank of America
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in charter)
|(State or other jurisdiction
|(Commission File Number)||(IRS Employer |
|(Address of principal executive offices)||(Zip Code)|
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)|
|Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))|
|Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))|
Securities registered pursuant to Section 12(b) of the Act: None
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
As previously reported on a Current Report on Form 8-K that was filed with the Securities and Exchange Commission on August 4, 2022, the Board of Genufood Energy Enzymes Corp. (the “Company”) unanimously approved to expand the Company’s business in the area of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such industry.
On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless technology and carbon-neutral vehicle-charging infrastructure.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|GENUFOOD ENERGY ENZYMES CORP.|
|Date: August 16, 2022||By:||/s/ David Tang|
|Chief Executive Officer|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EXL named a Leader in ISG Provider Lens™ Power and Utilities Services and Solutions report
- Clinisys completes combination of Sunquest, HORIZON and ApolloLIMS businesses
- Falcon Gold Acquires Strategic Nickel Copper Claim Group Contiguous To Go Metal’s HSP Property
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!